EXO Biologics
PrivateLast Round
Series A
Apr 24, 2024
Total Funding Raised
$27.56M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
EXO Biologics operates in Healthcare & Life Sciences and is based in Liège. Its latest recorded funding round was a Series A round in April 2024.
EXO Biologics is a biopharma company that is developing biopharmaceuticals using Extracellular Vesicles (EVs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EXO Biologics Comparables
Compare EXO Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EVerZom | 86% | |
| ILIAS Biologics Inc. | 78% | |
| Evox Therapeutics | 76% |
For institutional investors. Book with your work email.
EXO Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 24, 2024 | ||||
| Grant | Feb 5, 2021 | ||||
| Convertible Debt | Feb 5, 2021 |
For institutional investors. Book with your work email.
EXO Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Series A, Convertible Debt |
| Founders Fund | Series A |
| Walloon Region (Belgium) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 1150% MoM, from 211 to 2.6K.
- Mar 27, 2025
Monthly visitors increased 141% MoM.
For institutional investors. Book with your work email.
EXO Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EXO Biologics's valuation, stock price, and market status.
Is EXO Biologics a public or private company?
EXO Biologics is a private company.
What is the current stock price of EXO Biologics?
EXO Biologics is a private company, so its shares have no public market price. Caplight tracks EXO Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EXO Biologics worth (valuation)?
Valuation information for EXO Biologics is not publicly available.
Can I buy EXO Biologics stock?
EXO Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EXO Biologics's last funding round?
EXO Biologics's most recent funding round was Series A on April 24, 2024.
Who are the main investors in EXO Biologics?
Key investors in EXO Biologics include Noshaq.
Will EXO Biologics IPO soon?
No public IPO plans have been announced for EXO Biologics.
How can I track EXO Biologics secondary market activity?
Caplight tracks bids, offers, and trades in EXO Biologics's shares on secondary markets.